Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes

Clinical trial NCT06267391 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06267391
Sponsor: Endogenex, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Type2diabetes Diabetes Mellitus, Type 2 Diabetes Type 2 Diabetes

Start date: 2024-05-01
Primary completion: 2027-02-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.